NCT00247260 Safety of 32P BioSilicon in Patients With Hepatocellular Carcinoma Status UNKNOWN Phase PHASE2
NCT00243633 Characterization of Focal Liver Lesions by Real-time Contrast-enhanced Ultrasound Imaging (CEUS) Status COMPLETED Phase NA
NCT00242502 Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery Status COMPLETED Phase PHASE2
NCT00230347 Evaluation of Stereotactic Radiosurgery For Liver Malignancies Status COMPLETED Phase PHASE1
NCT00191412 A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver Status COMPLETED Phase PHASE2
NCT00185874 Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases Status TERMINATED Phase PHASE1
NCT00183885 A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT00152087 A Non-Randomized Study of Internal Radiation Therapy to the Liver in Patients With Primary Liver Cancer for Whom Surgery is Not Possible. Status UNKNOWN Phase PHASE2
NCT00151671 Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer Status TERMINATED Phase PHASE2/PHASE3
NCT00132041 Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis Status COMPLETED Phase NA
NCT00128596 Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT00109954 Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE3
NCT00095992 SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer Status COMPLETED Phase PHASE2
NCT00093548 Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT00093444 Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors Status COMPLETED Phase PHASE1
NCT00087282 Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer Status COMPLETED Phase PHASE2
NCT00081094 Positron Emission Tomography Using Carbon-11 Acetate and Fludeoxyglucose F 18 in Detecting Hepatocellular Carcinoma (Liver Cancer) in Patients With Known or Suspected Liver Cancer Status COMPLETED Phase NA
NCT00079027 Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) Status UNKNOWN Phase PHASE3
NCT00077389 Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma Status UNKNOWN Phase PHASE2